Home/Filings/4/0001209191-17-041829
4//SEC Filing

Conatus Pharmaceuticals Inc. 4

Accession 0001209191-17-041829

CIK 0001383701operating

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:14 PM ET

Size

5.7 KB

Accession

0001209191-17-041829

Insider Transaction Report

Form 4
Period: 2017-06-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-06-22+20,00020,000 total
    Exercise: $4.96Exp: 2027-06-21Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option become exercisable as the shares vest. The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Issuer

Conatus Pharmaceuticals Inc.

CIK 0001383701

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001383701

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:14 PM ET
Size
5.7 KB